The transcranial magnetic stimulator market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of depression and neurological disorders, growing awareness of non-pharmacological therapies, availability of FDA-approved tms systems, expansion of mental health clinics, rising acceptance of neuromodulation therapies.
The transcranial magnetic stimulator market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing adoption of tms for broader neurological indications, rising demand for personalized mental health treatments, expansion of outpatient psychiatric care, growing integration of digital treatment monitoring, increasing investments in neuromodulation research. Major trends in the forecast period include increasing adoption of non-invasive brain stimulation therapies, rising use of rtms in depression treatment, growing expansion of dtms clinical applications, enhanced focus on personalized neurostimulation protocols, expansion of outpatient mental health treatments.
The growth of the transcranial magnetic stimulator market is expected to be fueled by the increasing prevalence of neurological diseases. Transcranial magnetic stimulation (TMS) has demonstrated promising outcomes in the treatment of various neurological and psychiatric disorders, offering a novel approach to addressing conditions such as stroke, spasticity, migraine, dementia, and movement disorders. For example, in March 2023, the World Health Organization (WHO) reported that approximately 280 million people worldwide were affected by depression. Hence, the growing prevalence of neurological diseases is anticipated to drive the growth of the transcranial magnetic stimulator market.
Major companies operating in the transcranial magnetic stimulator market are focusing on developing innovative advancements such as neuronavigational-guided TMS systems to improve coil placement accuracy, enhance treatment consistency, and streamline clinical workflows. A neuronavigational-guided TMS system refers to an image-based guidance platform that integrates patient-specific neuroimaging with real-time coil tracking to ensure precise and reproducible stimulation targeting during transcranial magnetic stimulation procedures. For example, in March 2023, MagVenture Inc., a US-based medical equipment manufacturer, introduced the MagVenture TMS Atlas Neuro Navigation System. This system enhances transcranial magnetic stimulator coil positioning through a time-saving, high-precision workflow that is both reliable and user-friendly. The Atlas system provides high precision and accuracy for clinical use, offering operators a greater range of movement during TMS treatments by eliminating line-of-sight concerns. It utilizes advanced technology to provide patients with a visual representation of their MRI scan and real-time tracking of the treatment coil to their head position, enabling their active participation in the procedure.
In December 2024, Neuronetics, Inc., a US-based provider of transcranial magnetic stimulation systems and neurotechnology solutions for mental health treatment, acquired Greenbrook TMS Inc. for an undisclosed amount. Through this acquisition, Neuronetics aims to expand its treatment network, strengthen its commercial presence, and accelerate access to transcranial magnetic stimulation therapies by integrating a large clinical service infrastructure with its technology platform. Greenbrook TMS Inc., based in Canada, provides outpatient transcranial magnetic stimulation services through a nationwide network of mental health treatment centers.
Major companies operating in the transcranial magnetic stimulator market are BrainsWay Ltd., Nexstim Plc., The Magstim Company Limited, Neuronetics Inc., MagVenture Inc., MAG & More GmbH, neurocare group AG, Neurosoft, Neuroelectrics, NeuroConn GmbH, Neurofield Inc., Axilum Robotics, Yiruide Neurotech, Brainbox Ltd., Remed Inc., Soterix Medical Inc., Sinovation Medical Technology Co. Ltd., Shenzhen Yingchi Technology Co. Ltd., Wuhan Greentek Bioengineering Co. Ltd., Vishee Medical Technology Co. Ltd.
North America was the largest region in the transcranial magnetic stimulator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global transcranial magnetic stimulator market report during the forecast period. The regions covered in the transcranial magnetic stimulator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transcranial magnetic stimulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transcranial magnetic stimulator market by increasing costs of imported magnetic coils, electronic control systems, cooling components, and precision manufacturing equipment. Mental health clinics and hospitals in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher system pricing and distribution costs. These tariffs are increasing capital investment requirements for providers. However, they are also encouraging local device assembly, regional manufacturing capabilities, and innovation in cost-efficient neuromodulation systems.
The transcranial magnetic stimulator market research report is one of a series of new reports that provides transcranial magnetic stimulator market statistics, including transcranial magnetic stimulator industry global market size, regional shares, competitors with a transcranial magnetic stimulator market share, detailed transcranial magnetic stimulator market segments, market trends and opportunities, and any further data you may need to thrive in the transcranial magnetic stimulator industry. This transcranial magnetic stimulator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transcranial magnetic stimulators (TMS) are non-invasive medical devices that utilize magnetic waves to activate neurons in the nervous system, aiming to alleviate symptoms of depression and other mental health and brain-related disorders. These devices are employed to stimulate neurons in the nervous system for therapeutic purposes.
The primary types of transcranial magnetic stimulators include deep transcranial magnetic stimulators (dTMS), repetitive TMS (rTMS), and other variations. Deep Transcranial Magnetic Stimulator (dTMS) is a specific type of transcranial magnetic stimulation (TMS) therapy utilizing magnetic fields to stimulate nerve cells in the brain, effectively addressing symptoms of depression. This form of therapy is applicable to both children and adults and finds use in diverse applications such as Parkinson's disease, depression, Alzheimer's disease, epilepsy, and more.
The transcranial magnetic stimulator market consists of sales of single-pulse and paired-pulse transcranial magnetic stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The transcranial magnetic stimulator market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing adoption of tms for broader neurological indications, rising demand for personalized mental health treatments, expansion of outpatient psychiatric care, growing integration of digital treatment monitoring, increasing investments in neuromodulation research. Major trends in the forecast period include increasing adoption of non-invasive brain stimulation therapies, rising use of rtms in depression treatment, growing expansion of dtms clinical applications, enhanced focus on personalized neurostimulation protocols, expansion of outpatient mental health treatments.
The growth of the transcranial magnetic stimulator market is expected to be fueled by the increasing prevalence of neurological diseases. Transcranial magnetic stimulation (TMS) has demonstrated promising outcomes in the treatment of various neurological and psychiatric disorders, offering a novel approach to addressing conditions such as stroke, spasticity, migraine, dementia, and movement disorders. For example, in March 2023, the World Health Organization (WHO) reported that approximately 280 million people worldwide were affected by depression. Hence, the growing prevalence of neurological diseases is anticipated to drive the growth of the transcranial magnetic stimulator market.
Major companies operating in the transcranial magnetic stimulator market are focusing on developing innovative advancements such as neuronavigational-guided TMS systems to improve coil placement accuracy, enhance treatment consistency, and streamline clinical workflows. A neuronavigational-guided TMS system refers to an image-based guidance platform that integrates patient-specific neuroimaging with real-time coil tracking to ensure precise and reproducible stimulation targeting during transcranial magnetic stimulation procedures. For example, in March 2023, MagVenture Inc., a US-based medical equipment manufacturer, introduced the MagVenture TMS Atlas Neuro Navigation System. This system enhances transcranial magnetic stimulator coil positioning through a time-saving, high-precision workflow that is both reliable and user-friendly. The Atlas system provides high precision and accuracy for clinical use, offering operators a greater range of movement during TMS treatments by eliminating line-of-sight concerns. It utilizes advanced technology to provide patients with a visual representation of their MRI scan and real-time tracking of the treatment coil to their head position, enabling their active participation in the procedure.
In December 2024, Neuronetics, Inc., a US-based provider of transcranial magnetic stimulation systems and neurotechnology solutions for mental health treatment, acquired Greenbrook TMS Inc. for an undisclosed amount. Through this acquisition, Neuronetics aims to expand its treatment network, strengthen its commercial presence, and accelerate access to transcranial magnetic stimulation therapies by integrating a large clinical service infrastructure with its technology platform. Greenbrook TMS Inc., based in Canada, provides outpatient transcranial magnetic stimulation services through a nationwide network of mental health treatment centers.
Major companies operating in the transcranial magnetic stimulator market are BrainsWay Ltd., Nexstim Plc., The Magstim Company Limited, Neuronetics Inc., MagVenture Inc., MAG & More GmbH, neurocare group AG, Neurosoft, Neuroelectrics, NeuroConn GmbH, Neurofield Inc., Axilum Robotics, Yiruide Neurotech, Brainbox Ltd., Remed Inc., Soterix Medical Inc., Sinovation Medical Technology Co. Ltd., Shenzhen Yingchi Technology Co. Ltd., Wuhan Greentek Bioengineering Co. Ltd., Vishee Medical Technology Co. Ltd.
North America was the largest region in the transcranial magnetic stimulator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global transcranial magnetic stimulator market report during the forecast period. The regions covered in the transcranial magnetic stimulator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transcranial magnetic stimulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transcranial magnetic stimulator market by increasing costs of imported magnetic coils, electronic control systems, cooling components, and precision manufacturing equipment. Mental health clinics and hospitals in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher system pricing and distribution costs. These tariffs are increasing capital investment requirements for providers. However, they are also encouraging local device assembly, regional manufacturing capabilities, and innovation in cost-efficient neuromodulation systems.
The transcranial magnetic stimulator market research report is one of a series of new reports that provides transcranial magnetic stimulator market statistics, including transcranial magnetic stimulator industry global market size, regional shares, competitors with a transcranial magnetic stimulator market share, detailed transcranial magnetic stimulator market segments, market trends and opportunities, and any further data you may need to thrive in the transcranial magnetic stimulator industry. This transcranial magnetic stimulator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transcranial magnetic stimulators (TMS) are non-invasive medical devices that utilize magnetic waves to activate neurons in the nervous system, aiming to alleviate symptoms of depression and other mental health and brain-related disorders. These devices are employed to stimulate neurons in the nervous system for therapeutic purposes.
The primary types of transcranial magnetic stimulators include deep transcranial magnetic stimulators (dTMS), repetitive TMS (rTMS), and other variations. Deep Transcranial Magnetic Stimulator (dTMS) is a specific type of transcranial magnetic stimulation (TMS) therapy utilizing magnetic fields to stimulate nerve cells in the brain, effectively addressing symptoms of depression. This form of therapy is applicable to both children and adults and finds use in diverse applications such as Parkinson's disease, depression, Alzheimer's disease, epilepsy, and more.
The transcranial magnetic stimulator market consists of sales of single-pulse and paired-pulse transcranial magnetic stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Transcranial Magnetic Stimulator Market Characteristics
3. Transcranial Magnetic Stimulator Market Supply Chain Analysis
4. Global Transcranial Magnetic Stimulator Market Trends and Strategies
5. Transcranial Magnetic Stimulator Market Analysis of End Use Industries
7. Global Transcranial Magnetic Stimulator Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Transcranial Magnetic Stimulator Total Addressable Market (TAM) Analysis for the Market
9. Transcranial Magnetic Stimulator Market Segmentation
10. Transcranial Magnetic Stimulator Market Regional and Country Analysis
11. Asia-Pacific Transcranial Magnetic Stimulator Market
12. China Transcranial Magnetic Stimulator Market
13. India Transcranial Magnetic Stimulator Market
14. Japan Transcranial Magnetic Stimulator Market
15. Australia Transcranial Magnetic Stimulator Market
16. Indonesia Transcranial Magnetic Stimulator Market
17. South Korea Transcranial Magnetic Stimulator Market
18. Taiwan Transcranial Magnetic Stimulator Market
19. South East Asia Transcranial Magnetic Stimulator Market
20. Western Europe Transcranial Magnetic Stimulator Market
21. UK Transcranial Magnetic Stimulator Market
22. Germany Transcranial Magnetic Stimulator Market
23. France Transcranial Magnetic Stimulator Market
24. Italy Transcranial Magnetic Stimulator Market
25. Spain Transcranial Magnetic Stimulator Market
26. Eastern Europe Transcranial Magnetic Stimulator Market
27. Russia Transcranial Magnetic Stimulator Market
28. North America Transcranial Magnetic Stimulator Market
29. USA Transcranial Magnetic Stimulator Market
30. Canada Transcranial Magnetic Stimulator Market
31. South America Transcranial Magnetic Stimulator Market
32. Brazil Transcranial Magnetic Stimulator Market
33. Middle East Transcranial Magnetic Stimulator Market
34. Africa Transcranial Magnetic Stimulator Market
36. Transcranial Magnetic Stimulator Market Competitive Landscape and Company Profiles
37. Transcranial Magnetic Stimulator Market Other Major and Innovative Companies
40. Transcranial Magnetic Stimulator Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Transcranial Magnetic Stimulator Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses transcranial magnetic stimulator market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for transcranial magnetic stimulator? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transcranial magnetic stimulator market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Deep Transcranial Magnetic Stimulation (dTMS) Systems; Repetitive Transcranial Magnetic Stimulation (rTMS) Systems; Theta Burst Stimulation (TBS) Systems2) By Treatment Protocol: High-Frequency TMS; Low-Frequency TMS; Intermittent Theta Burst Stimulation (iTBS); Continuous Theta Burst Stimulation (cTBS)
3) By Application: Major Depressive Disorder (MDD); Treatment-Resistant Depression (TRD); Obsessive-Compulsive Disorder (OCD); Parkinson’s Disease; Alzheimer’s Disease and Other Dementias; Epilepsy; Other Applications
Subsegments:
1) By Deep Transcranial Magnetic Stimulation (dTMS) Systems: FDA-Approved dTMS Systems; Coil-Based Deep Stimulation Systems2) By Repetitive Transcranial Magnetic Stimulation (rTMS) Systems: Standard rTMS Systems; Navigated rTMS Systems
3) By Theta Burst Stimulation (TBS) Systems: Standalone TBS Systems; TBS-Enabled rTMS Platforms
Companies Mentioned: BrainsWay Ltd.; Nexstim Plc.; The Magstim Company Limited; Neuronetics Inc.; MagVenture Inc.; MAG & More GmbH; neurocare group AG; Neurosoft; Neuroelectrics; NeuroConn GmbH; Neurofield Inc.; Axilum Robotics; Yiruide Neurotech; Brainbox Ltd.; Remed Inc.; Soterix Medical Inc.; Sinovation Medical Technology Co. Ltd.; Shenzhen Yingchi Technology Co. Ltd.; Wuhan Greentek Bioengineering Co. Ltd.; Vishee Medical Technology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Transcranial Magnetic Stimulator market report include:- BrainsWay Ltd.
- Nexstim Plc.
- The Magstim Company Limited
- Neuronetics Inc.
- MagVenture Inc.
- MAG & More GmbH
- neurocare group AG
- Neurosoft
- Neuroelectrics
- NeuroConn GmbH
- Neurofield Inc.
- Axilum Robotics
- Yiruide Neurotech
- Brainbox Ltd.
- Remed Inc.
- Soterix Medical Inc.
- Sinovation Medical Technology Co. Ltd.
- Shenzhen Yingchi Technology Co. Ltd.
- Wuhan Greentek Bioengineering Co. Ltd.
- Vishee Medical Technology Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 2.21 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
